ER-POSITIVE HER2-NEGATIVE BREAST CANCER
Clinical trials for ER-POSITIVE HER2-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ER-POSITIVE HER2-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ER-POSITIVE HER2-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer: early trial of H3B-6545 in japanese women
Disease control CompletedThis early-phase study tested a new oral drug called H3B-6545 in 33 Japanese women with a common type of breast cancer (ER-positive, HER2-negative). The main goal was to see if the drug is safe and tolerable, and to find the right dose for Japanese patients. Participants had alre…
Matched conditions: ER-POSITIVE HER2-NEGATIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for breast cancer: personalized Pre-Surgery drug combo shows promise
Knowledge-focused CompletedThis study looked at whether adding a drug that targets specific genetic changes in breast tumors could slow cancer growth more than standard hormone therapy alone. It involved 19 people with ER-positive, HER2-negative breast cancer who received treatment before surgery. The goal…
Matched conditions: ER-POSITIVE HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC